A disproportionality analysis of real-world adverse events associated with tirofiban from the FAERS database
Tirofiban, as a GP IIb/IIIa receptor antagonist, competitively inhibits the bridging of platelets via fibrin, which is the…
#NewsBeep #News #Headlines #Adverseevent #bleeding #cardiology #Disproportionalityanalysis #FAERS #HumanitiesandSocialSciences #Latvia #LV #Medicalresearch #multidisciplinary #Neurology #Science #Tirofiban
https://www.newsbeep.com/95720/
